Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
New tuberculosis vaccines are urgently needed to curtail the current epidemic. MVA85A is a subunit vaccine that could enhance immunity from BCG vaccination. To determine MVA85A safety and immunogenicity as well as interactions with other routine vaccines administered in infancy, we randomized health...
Những tác giả chính: | Ota, M, Odutola, A, Owiafe, P, Donkor, S, Owolabi, O, Brittain, N, Williams, N, Rowland-Jones, S, Hill, A, Adegbola, R, Mcshane, H |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2011
|
Những quyển sách tương tự
-
Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
Bằng: Ota, M, et al.
Được phát hành: (2011) -
A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
Bằng: Odutola, A, et al.
Được phát hành: (2012) -
A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Bằng: Odutola, A, et al.
Được phát hành: (2012) -
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Brookes, R, et al.
Được phát hành: (2008) -
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Bằng: Roger H Brookes, et al.
Được phát hành: (2008-08-01)